MedPath

AFTER – Ankle fracture treatment: enhancing rehabilitation trial

Not Applicable
Conditions
Ankle fracture
Musculoskeletal Diseases
Registration Number
ISRCTN11830323
Lead Sponsor
niversity of Oxford
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
377
Inclusion Criteria

1. Patient is aged 50 years and over with an ankle fracture undergoing surgical fixation or nonsurgical management
2. Patient is provided with a cast or orthotic boot (non-removable or removable for non-weight bearing ankle movement) for at least 4 weeks and no longer than 10 weeks
3. Patient has capacity to consent to trial participation within 14 days of removal of the cast/boot

Exclusion Criteria

1. Patient is deemed unable to adhere to trial procedures or complete questionnaires
2. Patient was not ambulatory before the injury
3. Patient has contraindications to participation in an exercise programme

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ankle function measured by Olerud and Molander Ankle Scale (OMAS) at 6 months post randomisation
Secondary Outcome Measures
NameTimeMethod
1. Ankle function measured by Olerud and Molander Ankle Scale (OMAS) at baseline and 2 and 4 months post randomisation.<br>2. Health-related quality of life measured by EQ-5D-5L at Baseline, 2, 4 and 6 months post-randomisation.<br>3. Pain, measured by pain sub-scales of the EQ-5D-5L and OMAS at Baseline, 2, 4 and 6 months post-randomisation.<br>4. Physical Function, measured by PROMIS Physical Function at Baseline, 4 and 6 months post-randomisation.<br>5. Self-efficacy measured by Self-Efficacy Exercise Score at Baseline, 4 and 6 months post-randomisation<br>6. Participant exercise adherence, measured with self-reported exercise frequency at 2, 4 and 6 months post-randomisation.<br>7. Participant complications, measured with complications questionnaire and Case Report Form at 2, 4 and 6 months post-randomisation.<br>8. Cost effectiveness of interventions measured with health economics questionnaire at 2 and 6 months post-randomisation
© Copyright 2025. All Rights Reserved by MedPath